Skip to main content

CORRECTION article

Front. Neurol., 23 March 2022
Sec. Multiple Sclerosis and Neuroimmunology

Corrigendum: Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy

\nChristopher M. Bartley,&#x;Christopher M. Bartley1,2Neelroop N. Parikshak,&#x;Neelroop N. Parikshak1,3Thomas T. Ngo,Thomas T. Ngo1,2Jessa A. Alexander,Jessa A. Alexander1,3Kelsey C. ZornKelsey C. Zorn4Bonny D. Alvarenga,Bonny D. Alvarenga1,3Min K. Kang,Min K. Kang1,3Massimo PedrialiMassimo Pedriali5Samuel J. Pleasure,Samuel J. Pleasure1,3Michael R. Wilson,
Michael R. Wilson1,3*
  • 1Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States
  • 2Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, United States
  • 3Department of Neurology, University of California, San Francisco, San Francisco, CA, United States
  • 4Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, United States
  • 5Operative Unit of Surgical Pathology, Azienda Ospedaliera-Universitaria, Ferrara, Italy

A Corrigendum on
Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy

by Bartley, C. M., Parikshak, N. N., Ngo, T. T., Alexander, J. A., Zorn, K. C., Alvarenga, B. D., Kang, M. K., Pedriali, M., Pleasure, S. J., and Wilson, M. R. (2021). Front. Neurol. 12:728700. doi: 10.3389/fneur.2021.728700

An author name was incorrectly spelled as Bonny A. Alvarenga. The correct spelling is Bonny D. Alvarenga.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: paraneoplastic neurologic disease, myelopathy, anti-Yo antibodies, phage display, breast cancer, CDR2L

Citation: Bartley CM, Parikshak NN, Ngo TT, Alexander JA, Zorn KC, Alvarenga BD, Kang MK, Pedriali M, Pleasure SJ and Wilson MR (2022) Corrigendum: Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy. Front. Neurol. 13:888513. doi: 10.3389/fneur.2022.888513

Received: 02 March 2022; Accepted: 04 March 2022;
Published: 23 March 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Bartley, Parikshak, Ngo, Alexander, Zorn, Alvarenga, Kang, Pedriali, Pleasure and Wilson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Michael R. Wilson, michael.wilson@ucsf.edu

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.